Clinical Trial: Personalized perioperative treatment decision-making of high-grade serous ovarian carcinoma and explorations on heterogeneity of immune microenvironment assisted by multi-omics and artificial intelligence models (China)

Posted On: 2026-08-18

China, Aug. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Personalized perioperative treatment decision-making of high-grade serous ovarian carcinoma and explorations on heterogeneity of immune microenvironment assisted by multi-omics and artificial intelligence models'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130181

Registration Time: 2026/08/17

Type: Observational study

Primary Sponsor: The Affiliated Hospital of Qingdao University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=327986

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Personalized perioperative treatment decision-making of high-grade serous ovarian carcinoma and explorations on heterogeneity of immune microenvironment assisted by multi-omics and artificial intelligence models (China)